date,title,source
Oct-19-18,MorphoSys's Licensee Janssen has Reported That New Tremfya(R) (Guselkumab) 3-Year Data Shows Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis,ACCESSWIRE
Nov-01-18,MorphoSys to Present Data on Investigational Drugs MOR208 and MOR202 in Various Blood Cancer Indications at ASH 2018 Meeting,ACCESSWIRE
Nov-05-18,DGAP-News: MorphoSys AG Announces Third Quarter 2018 Results,ACCESSWIRE
